FIGURE 2.
Time course for HbA1c (upper panels) and fasting plasma glucose (FPG; lower panels) during the 18-month treatment period. Data are model adjusted mean ± se. Left-hand panels show addition of rosiglitazone (▵; n = 253) or sulfonylurea (▴; n = 263) to metformin; right-hand panels show addition of rosiglitazone (□; n = 301) or metformin (▪; n = 272) to sulfonylurea.